Join us on March 16 when we arrange the first virtual BioStock Investor Meeting of 2023. The event gives representatives from a number of life science companies active in a wide range of therapeutic areas the opportunity to present their business case to investors and potential partners. The full program is presented below.
10.20 Xbrane Biopharma
11.00 Chordate Medical
11.20 Aqilion – Expert insights
11.40 QuiaPEG Pharmaceuticals
12.20 Arcede Pharma
12.40 Closing remarks and information about upcoming events
The video content is sponsored by the company that appears in the video. BioStock does not provide investment advice, mediates no investment orders and assumes no responsibility for actions and/or possible loss or damage of any kind based on the use of content published on BioStock.se. Each investment decision is instead made independently by the individual investor.
Regarding QuiaPEG Pharmaceuticals’ right issue: This material has been prepared for marketing purposes. The full terms and conditions for the rights issue and more information about the company have been reported in the prospectus that was published and published on www.quiapeg.com on March 14, 2023. The prospectus has been approved and registered by the Financial Supervisory Authority.
Subscribe and follow BioStock on:
#BioStock #LifeScience #InvestorMeeting
BioStock is Scandinavia’s leading digital news and analysis service with an exclusive focus on the Life Science sector. Our primary editorial office is found at Medicon Village in Lund, one of Sweden’s foremost innovation clusters for life science companies, while our second editorial office is located in central Stockholm with proximity to both life science companies and financial players. We have TV studios on both sites.